CIK: 1218808 - Address: C/o Dara Biosciences, Inc., 8601 Six Forks Rd, Suite 160, Raleigh, NC 27615
19 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

P%ret11144222836120
P%wins100100100100100100100
S%ret1113244314-54
S%wins62467762156254

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

6/4/13 16:10
6/3/13
DARADara Biosciences, Inc.DEHealthDrugPharmaceutical PreparationsClement Christopher GNCDOPP100.71260145273D
12/10/08 16:00
12/9/08
SVNTSavient Pharmaceuticals IncDEHealthMdCmMedicinal Chemicals & BotanicClement Christopher GNJHFormer PS.e-454.795-9-3277D-63-71-82-7744221185461523192
4/16/08 15:43
4/14/08
SVNTSavient Pharmaceuticals IncDEHealthMdCmMedicinal Chemicals & BotanicClement Christopher GNJOP,CEOS-14419.0622-8-3247D2215126-12-18-2-10-3322546-38-74
2/20/08 16:59
2/15/08
SVNTSavient Pharmaceuticals IncDEHealthMdCmMedicinal Chemicals & BotanicClement Christopher GNJOP,CEOS.d-22220.0019-11-4240D352437967-10412213-16811-72
1/17/08 17:12
1/7/08
SVNTSavient Pharmaceuticals IncDEHealthMdCmMedicinal Chemicals & BotanicClement Christopher GNJOP,CEOS.adm-34022.6830-15-6252D40336643654-13-11-7030-229-66
1/17/08 17:12
1/8/08
SVNTSavient Pharmaceuticals IncDEHealthMdCmMedicinal Chemicals & BotanicClement Christopher GNJOP,CEOM.adm192.783073252D40336643654-13-11-7030-229-66
1/17/08 17:12
1/15/08
SVNTSavient Pharmaceuticals IncDEHealthMdCmMedicinal Chemicals & BotanicClement Christopher GNJOP,CEOM.dm442.9330156252D40336643654-13-11-7030-229-66
1/17/08 17:12
1/15/08
SVNTSavient Pharmaceuticals IncDEHealthMdCmMedicinal Chemicals & BotanicClement Christopher GNJOP,CEOS.dm-31420.9630-15-6252D40336643654-13-11-7030-229-66
1/14/08 17:13
1/10/08
SVNTSavient Pharmaceuticals IncDEHealthMdCmMedicinal Chemicals & BotanicClement Christopher GNJOP,CEOM.dm422.7833156251D416567451585-8-3-2-6-8-1123-62
1/14/08 17:13
1/10/08
SVNTSavient Pharmaceuticals IncDEHealthMdCmMedicinal Chemicals & BotanicClement Christopher GNJOP,CEOS.dm-33022.0233-15-6251D416567451585-8-3-2-6-8-1123-62
1/9/08 17:33
1/7/08
SVNTSavient Pharmaceuticals IncDEHealthMdCmMedicinal Chemicals & BotanicClement Christopher GNJOP,CEOS.dm-34422.6933-15-6251D4847887519212-1-50-3-6-1319-63
1/9/08 17:33
1/8/08
SVNTSavient Pharmaceuticals IncDEHealthMdCmMedicinal Chemicals & BotanicClement Christopher GNJOP,CEOM.dm192.783373251D4847887519212-1-50-3-6-1319-63
1/4/08 16:48
1/2/08
SVNTSavient Pharmaceuticals IncDEHealthMdCmMedicinal Chemicals & BotanicClement Christopher GNJOP,CEOS.m-24124.0933-10-4260D543103965895661150-4-13-87-69
12/12/07 16:53
12/10/07
SVNTSavient Pharmaceuticals IncDEHealthMdCmMedicinal Chemicals & BotanicClement Christopher GNJOP,CEOS-17115.2616-11-4270D275188101151-41843533267-67
4/16/07 15:22
4/12/07
SVNTSavient Pharmaceuticals IncDEHealthMdCmMedicinal Chemicals & BotanicClement Christopher GNJOP,CEOS-9112.009-8-3281D36511982-84188-2-8-3-21350
3/7/07 16:47
3/5/07
SVNTSavient Pharmaceuticals IncDEHealthMdCmMedicinal Chemicals & BotanicClement Christopher GNJOP,CEOS-43112.5912-34-11288D36215610011-12-11-10015-68478
2/20/07 17:12
2/15/07
SVNTSavient Pharmaceuticals IncDEHealthMdCmMedicinal Chemicals & BotanicClement Christopher GNJOP,CEOS.d-11014.4912-8-3248D3862161534825-4-40-2-1-17-9-2340
4/13/06 13:37
4/12/06
SVNTSavient Pharmaceuticals IncDEHealthMdCmMedicinal Chemicals & BotanicClement Christopher GNJOP,CEOS-615.872-10-7146-3-2-16-918112
5/19/05 09:13
5/18/05
SVNTSavient Pharmaceuticals IncDEHealthMdCmMedicinal Chemicals & BotanicClement Christopher GNJOP,CEOP463.0911516106D-2034385201874442228361

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact